Hasil Pencarian - James R Hunter

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2?

    Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2? oleh Robert M. Lloyd Jr, James R. Hunter, Ricardo Sobhie Diaz, Mauro Schechter

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess

    T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess oleh Nathalia Mantovani Pena, Luiz Claudio Santana, James R Hunter, Vinicius Fontanesi Blum, Tania Vergara, Celso Gouvea, Elcio Leal, Nancy Bellei, Mauro Schechter, Ricardo Sobhie Diaz

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Antiretroviral Drug-Resistance Mutations on the <i>Gag</i> Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure

    Antiretroviral Drug-Resistance Mutations on the <i>Gag</i> Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure oleh James R. Hunter, Domingos E. Matos dos Santos, Patricia Munerato, Luiz Mario Janini, Adauto Castelo, Maria Cecilia Sucupira, Hong-Ha M. Truong, Ricardo Sobhie Diaz

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Fitness Cost of Antiretroviral Drug Resistance Mutations on the <i>pol</i> Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure

    Fitness Cost of Antiretroviral Drug Resistance Mutations on the <i>pol</i> Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological F... oleh James R. Hunter, Domingos E. Matos dos Santos, Patricia Munerato, Luiz Mario Janini, Adauto Castelo, Maria Cecilia Sucupira, Hong-Ha M. Truong, Ricardo Sobhie Diaz

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

    Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil oleh Ricardo Sobhie Diaz, James R. Hunter, Michelle Camargo, Danilo Dias, Juliana Galinskas, Isabela Nassar, Isaac Barbosa de Lima, Debora Bellini Caldeira, Maria Cecilia Sucupira, Mauro Schechter

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16

    Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16 oleh Willames M. B. S. Martins, Mei Li, Kirsty Sands, Michael H. Lenzi, Edward Portal, Jordan Mathias, Priscila P. Dantas, Roberta Migliavacca, James R. Hunter, Eduardo A. Medeiros, Ana C. Gales, Mark A. Toleman

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

    Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial. oleh Vinicius Fontanesi Blum, Sérgio Cimerman, James R Hunter, Paulo Tierno, Acioly Lacerda, Alexandre Soeiro, Florentino Cardoso, Nancy Cristina Bellei, Juliana Maricato, Nathalia Mantovani, Marcella Vassao, Danilo Dias, Juliana Galinskas, Luis Mário Ramos Janini, Joanna Reis Santos-Oliveira, Alda Maria Da-Cruz, Ricardo Sobhie Diaz

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

    Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial oleh Marcella Vassão de Almeida Baptista, Laís Teodoro da Silva, Sadia Samer, Telma Miyuki Oshiro, Iart Luca Shytaj, Leila B. Giron, Nathalia Mantovani Pena, Nicolly Cruz, Gisele Cristina Gosuen, Paulo Roberto Abrão Ferreira, Edécio Cunha-Neto, Juliana Galinskas, Danilo Dias, Maria Cecilia Araripe Sucupira, Cesar de Almeida-Neto, Reinaldo Salomão, Alberto José da Silva Duarte, Luís Mário Janini, James R. Hunter, Andrea Savarino, Maria Aparecida Juliano, Ricardo Sobhie Diaz

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

    Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 1009... oleh Vinicius Fontanesi Blum, MD, MSc, Sérgio Cimerman, MD, PhD, James R Hunter, PhD, Paulo Tierno, MD, Acioly Lacerda, Alexandre Soeiro, MD, Florentino Cardoso, MD, Nancy Cristina Bellei, PhD, MD, Juliana Maricato, PhD, Nathalia Mantovani, PhD, Marcella Vassao, MSc, Danilo Dias, Juliana Galinskas, Luis Mário Ramos Janini, MD, PhD, Joanna Reis Santos-Oliveira, PhD, Alda Maria Da-Cruz, MD, PhD, Ricardo Sobhie Diaz, MD, PhD

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: